Title : Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?

Pub. Date : 2015

PMID : 26197437






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Fingolimod, an immune modulatory drug whose structure is similar to S1P, has been approved for treatment in multiple sclerosis (MS): fingolimod reduces the rate of MS relapses by preventing leukocyte egress from the lymph nodes. Fingolimod Hydrochloride membrane bound transcription factor peptidase, site 1 Homo sapiens
2 Fingolimod, an immune modulatory drug whose structure is similar to S1P, has been approved for treatment in multiple sclerosis (MS): fingolimod reduces the rate of MS relapses by preventing leukocyte egress from the lymph nodes. Fingolimod Hydrochloride membrane bound transcription factor peptidase, site 1 Homo sapiens